ORGO LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Organogenesis Holdings Inc.

January 24, 2022 11:11 AM EST | Source: Vincent Wong Esq.

New York, New York--(Newsfile Corp. - January 24, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO) between March 17, 2021 and October 11, 2021.

If you suffered a loss, contact us at the link below. There is no cost or obligation to you.
https://www.wongesq.com/pslra-1/organogenesis-holdings-inc-loss-submission-form?prid=22387&wire=5

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7094/111351_508535_logo.jpg

Allegations against ORGO include that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result of all the foregoing, the Company's revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you suffered a loss in Organogenesis you have until February 8, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/111351

info